SCHEMBL4573471

SCHEMBL4573471

CC(C)(C#N)c1ccc(N2CCNCC2)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 9/20 0.56
DRD2 P14416 1/20 0.46
DRD3 P35462 1/20 0.46
HTR3E A5X5Y0 3/20 0.45
HTR3B O95264 3/20 0.45
HTR3A P46098 3/20 0.45
HTR3D Q70Z44 3/20 0.45
HTR3C Q8WXA8 3/20 0.45
SIGMAR1 Q99720 3/20 0.45
HTR1A P08908 2/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
THRB P10828 1/20 0.44
CYP2C9 P11712 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
SLC6A4 P31645 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4573103 0.84 ADRB1 (0.58) ADRB1DRD2DRD3HTR3EHTR3B
SCHEMBL26074538 0.84 ADRB1 (0.65) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4573317 0.81 HTR1A (0.50) ADRB1DRD2DRD3HTR3EHTR3B
SCHEMBL1471288 0.78 ADRB1 (0.65) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4573172 0.76 ADRB1 (0.53) ADRB1DRD2DRD3HTR3EHTR3B
SCHEMBL4573292 0.76 ADRB1 (0.54) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL4428637 0.75 ADRB1 (0.65) ADRB1DRD2DRD3HTR3EHTR3B
SCHEMBL2984679 0.74 ADRB1 (0.73) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL232689 0.73 ADRB1 (1.00) ADRB1HTR3EHTR3BHTR3AHTR3D
Hydrochloric Acid SCHEMBL2959681 0.72 ADRB1 (0.96) ADRB1HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009001127-A1 CYANOCYCLOPROPYLCARBOXAMIDES AS CATHEPSIN INHIBITORS ASTRAZENECA AB (SE) 2008-12-31 WO disclosed